Parkinson's Disease Trial, Recruiting (NCT07094269)

Parkinson's Disease Trial, Recruiting NCT07094269 Sponsor: Universita degli Studi di Genova Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07094269 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are older than 18 years of age
You have been diagnosed with idiopathic Parkinson's disease (a form of Parkinson's disease with no known specific cause)
Your Parkinson's disease is at a mild to moderate stage, as measured by a standard rating scale called Hoehn and Yahr (stage 3.5 or below) (confirm with trial site)
You experience significant fatigue, scoring 4 or above on a standard fatigue questionnaire called the Fatigue Severity Scale (confirm with trial site)

Who may not be able to join:

You have significant difficulties with memory or thinking, shown by scoring below 22 on a standard cognitive test called the Montreal Cognitive Assessment (confirm with trial site)
You have other health conditions that could be causing your fatigue on their own
You are not fluent in the Italian language
You have a condition called Parkinsonism, which refers to Parkinson's-like symptoms caused by something other than idiopathic Parkinson's disease (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +393482609897

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07094269

Sponsor: Universita degli Studi di Genova

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: +393482609897

More information: https://clinicaltrials.gov/study/NCT07094269

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are older than 18 years of age
You have been diagnosed with idiopathic Parkinson's disease (a form of Parkinson's disease with no known specific cause)
Your Parkinson's disease is at a mild to moderate stage, as measured by a standard rating scale called Hoehn and Yahr (stage 3.5 or below) (confirm with trial site)
You experience significant fatigue, scoring 4 or above on a standard fatigue questionnaire called the Fatigue Severity Scale (confirm with trial site)

Who may not be able to join:

You have significant difficulties with memory or thinking, shown by scoring below 22 on a standard cognitive test called the Montreal Cognitive Assessment (confirm with trial site)
You have other health conditions that could be causing your fatigue on their own
You are not fluent in the Italian language
You have a condition called Parkinsonism, which refers to Parkinson's-like symptoms caused by something other than idiopathic Parkinson's disease (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Universita degli Studi di Genova

Registry

ClinicalTrials.gov

Start date

1 July 2025

Est. completion

1 June 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Self-Efficacy for Performing Energy Conservation Strategies Assessment (SEPECSA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov